Search
- Page Path
- HOME > Search
Review Article
- Anti-inflammatory effects of colchicine on coronary artery disease
- Hun-Jun Park
- Cardiovasc Prev Pharmacother. 2022;4(1):7-12. Published online January 20, 2022
- DOI: https://doi.org/10.36011/cpp.2022.4.e5
- 8,033 View
- 178 Download
- 1 Citations
-
Abstract
PDF - Inflammation plays a crucial role in the pathophysiology of coronary artery disease (CAD). Several types of sterile inflammation are mediated through the nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome. Colchicine has recently been shown to effectively block NLRP3 inflammasome assembly in addition to several other actions on inflammatory cells. Recent evidence also points to favorable effects of colchicine in patients with CAD, including lower levels of inflammatory markers, coronary plaque stabilization, and more favorable cardiac recovery after injury. This review focuses on the role of colchicine in the process of atherosclerosis and discusses its potential as a therapeutic option for the prevention and treatment of CAD.
-
Citations
Citations to this article as recorded by
- The Action of Colchicine in Patients with Metabolic Syndrome and Obesity: Perspectives and Challenges
Fábio Vieira de Bulhões, Gabriele Eliza Assis, Ana Beatriz Cazé, Jackson Pedro Barros-Pereira, Gabriela Garcia de Carvalho Laguna, Alex Cleber Improta-Caria, Roque Aras-Júnior
Metabolites.2024; 14(11): 629. CrossRef
- The Action of Colchicine in Patients with Metabolic Syndrome and Obesity: Perspectives and Challenges
First
Prev
